| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/17/2005 | US20050255038 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
| 11/17/2005 | US20050255001 Portable sample analyzer with removable cartridge |
| 11/17/2005 | US20050255000 microchip which, on a substrate, is provided with a reaction bath section, a sample solution supply channel for supplying sample solution for analysis, a buffer solution supply channel for supplying buffer solution, and a waste solution channel for discharging the solutions to outside; low cost |
| 11/17/2005 | US20050254999 Clinical specimen processing apparatus and clinical specimen processing system |
| 11/17/2005 | US20050254996 Chemical agent detection |
| 11/17/2005 | US20050254062 Fiber-optic assay apparatus based on phase-shift interferometry |
| 11/17/2005 | US20050253601 Electric conductivity water probe |
| 11/17/2005 | US20050253599 Fuel sensor |
| 11/17/2005 | US20050253154 LED bonding structures and methods of fabricating LED bonding structures |
| 11/17/2005 | US20050252789 Hydrogen sensing apparatus and method |
| 11/17/2005 | US20050252777 Addressable chem/bio chip array |
| 11/17/2005 | US20050252769 Electric-current biosensor |
| 11/17/2005 | US20050252286 Method and system for reservoir characterization in connection with drilling operations |
| 11/17/2005 | US20050252281 System and method for treating process fluids delivered to an electrochemical cell stack |
| 11/17/2005 | US20050252280 Polymer melt and elastomer extension fixture |
| 11/17/2005 | US20050252275 Odor measuring apparatus |
| 11/17/2005 | US20050252274 Method and apparatus for determining the efficiency of a vaporizer in a decontamination system |
| 11/17/2005 | US20050252273 Gas detection device |
| 11/17/2005 | DE3909227B4 Verfahren zum Nachweis von zersetzungsfähigen organischen Kohlenstoffverbindungen die in einer gasförmigen oder flüssigen Phase vorliegen A method for detecting decomposable organic carbon compounds present in a gaseous or liquid phase |
| 11/17/2005 | DE10393273T5 Ausscheidung von anorganischem Kohlenstoff Excretion of inorganic carbon |
| 11/17/2005 | DE102004021351A1 Funktionalisierter poröser Träger für Mikroarrays Functionalized porous carrier for microarrays |
| 11/17/2005 | DE102004020287A1 Apparatus for determining the energy content of a gas flowing in a pipeline comprises an analysis unit, a flow meter and a mounting pipe assembled into a single unit |
| 11/17/2005 | DE102004019641A1 FET-basierter Gassensor FET-based gas sensor |
| 11/17/2005 | DE102004019640A1 Verfahren zur Erhöhung der Selektivität von FET-basierten Gassensoren A method for increasing the selectivity of the FET-based gas sensors |
| 11/17/2005 | DE102004019639A1 FET-basierter Gassensor FET-based gas sensor |
| 11/17/2005 | DE102004019357A1 Verfahren zur Funktionalisierung von Biosensor-Chips A process for the functionalization of biosensor chips |
| 11/17/2005 | DE102004008321B3 Verfahren und Vorrichtung zur Qualitätsüberwachung bei der Herstellung von Tabletten Method and device for quality control in the manufacture of tablets |
| 11/17/2005 | DE10050942B4 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations |
| 11/17/2005 | CA2608177A1 Methods for determining conformational changes and self-assembly of proteins |
| 11/17/2005 | CA2566549A1 A method for isolating mammary stem cells |
| 11/17/2005 | CA2566455A1 Synthesis and biological activity of bicyclic aba analogs |
| 11/17/2005 | CA2566101A1 Novel soluble cd14 antigen |
| 11/17/2005 | CA2566041A1 T-type calcium channel splice variant compositions and methods |
| 11/17/2005 | CA2565858A1 Assay for drug discovery based on in vitro differentiated cells |
| 11/17/2005 | CA2565855A1 Patterned cell network substrate interface and methods and uses thereof |
| 11/17/2005 | CA2565773A1 Methods and systems for detection, identification and quantitation of macrolides and their impurities |
| 11/17/2005 | CA2565679A1 Device and method for detecting molecular interactions |
| 11/17/2005 | CA2565676A1 Gm3 synthase as a therapeutic target in microvascular complications of diabetes |
| 11/17/2005 | CA2565393A1 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 11/17/2005 | CA2565224A1 Methods and systems for detection of macrolides |
| 11/17/2005 | CA2565043A1 Methods of treating demyelinating disorders |
| 11/17/2005 | CA2564850A1 Mn/ca ix/ ca9 and renal cancer prognosis |
| 11/17/2005 | CA2564511A1 Fast perfusion system and patch clamp technique utilizing an interface chamber system having high throughput and low volume requirements |
| 11/17/2005 | CA2564292A1 Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter |
| 11/17/2005 | CA2563522A1 Device for determining composition of a fluid mixture |
| 11/17/2005 | CA2563510A1 Method for preparing substrates having immobilized molecules and substrates |
| 11/17/2005 | CA2563334A1 Assay for antibodies |
| 11/17/2005 | CA2563168A1 Nucleic-acid programmable protein arrays |
| 11/17/2005 | CA2563080A1 Monoclonal antibodies to hepatocyte growth factor |
| 11/17/2005 | CA2561901A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 11/17/2005 | CA2561684A1 Real time method of detecting acute inflammatory conditions |
| 11/17/2005 | CA2560865A1 Cancer associated antigens |
| 11/17/2005 | CA2560264A1 Gm1 promoter and use thereof |
| 11/16/2005 | EP1596199A1 Method for the detection of disease-related prion |
| 11/16/2005 | EP1596198A1 Method of measuring oxidized ldl-crp complex and measrurement kit |
| 11/16/2005 | EP1596197A1 Method and device for determining the mechanical properties of materials |
| 11/16/2005 | EP1596196A2 Protein interaction chip |
| 11/16/2005 | EP1596192A1 Methode for separating proteins by capillary electrophoresis and buffer composition for capillary electrophoresis |
| 11/16/2005 | EP1596190A1 Sensor |
| 11/16/2005 | EP1596189A1 Measuring instrument for biosensor and measuring method using same |
| 11/16/2005 | EP1596184A2 Method for spectrometrically measuring isotopic gas and apparatus thereof |
| 11/16/2005 | EP1596183A2 Method for spectrometrically measuring isotopic gas and apparatus thereof |
| 11/16/2005 | EP1596182A2 Method for spectrometrically measuring isotopic gas and apparatus thereof |
| 11/16/2005 | EP1596181A2 Method for spectrometrically measuring isotopic gas and apparatus thereof |
| 11/16/2005 | EP1595957A1 Phosphoglycerate mutases and enzyme products |
| 11/16/2005 | EP1595952A1 Method of estimating antitumor effect of histone deacetylase inhibitor |
| 11/16/2005 | EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies |
| 11/16/2005 | EP1595950A1 Method of measuring homocysteine |
| 11/16/2005 | EP1595947A1 MN gene and protein |
| 11/16/2005 | EP1595890A2 Synthetic peptide inhibitors of HIV transmission |
| 11/16/2005 | EP1595889A1 Method of eliminating phosphate group of peptide and method of analyzing peptide |
| 11/16/2005 | EP1595872A1 Fluorescent compounds for monitoring protein-lipid binding |
| 11/16/2005 | EP1595605A1 Method for coating with a hydrophilic composition fluid transport elements and apparatus comprising said fluid transport elements |
| 11/16/2005 | EP1595573A2 Stent comprising manipulators of nitrosative stress to reduce restenosis |
| 11/16/2005 | EP1595548A2 Anti-neovasculature preparations for treating cancer |
| 11/16/2005 | EP1595146A1 Screening assays for cannabinoid-ligand-type modulators of gpr55 |
| 11/16/2005 | EP1595145A2 Methods for the treatment of renal cell carcinoma |
| 11/16/2005 | EP1595144A1 Microarray devices having controllable reaction volume |
| 11/16/2005 | EP1595143A1 The detection and identification of saxiphilins using saxitoxin-biotin conjugates |
| 11/16/2005 | EP1595142A2 Method for evaluating the efficacy of certain cancer treatments |
| 11/16/2005 | EP1595141A2 Diagnostic device and method |
| 11/16/2005 | EP1595136A1 Apparatus and method for blood analysis |
| 11/16/2005 | EP1595132A2 Method for analysis of contaminants in a process fluid stream |
| 11/16/2005 | EP1595129A2 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 11/16/2005 | EP1595128A2 Method and apparatus for enhanced detection of a specie using a gas chromatograph |
| 11/16/2005 | EP1595127A2 Chip-in-a-well scanning |
| 11/16/2005 | EP1594989A2 Methods for the early diagnosis of ovarian cancer |
| 11/16/2005 | EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof |
| 11/16/2005 | EP1594983A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 11/16/2005 | EP1594979A2 Nanocylinder-modified surfaces |
| 11/16/2005 | EP1594962A2 Covalent tethering of functional groups to proteins |
| 11/16/2005 | EP1594900A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 11/16/2005 | EP1594893A2 Therapeutic targets in cancer |
| 11/16/2005 | EP1594891A1 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 11/16/2005 | EP1594890A1 Peptide derived from a vca-p18 capside antigen of the epstein-barr virus and the use thereof |
| 11/16/2005 | EP1594860A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 11/16/2005 | EP1594855A2 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 11/16/2005 | EP1594614A2 Improved device and method for separation of blood components |
| 11/16/2005 | EP1594612A1 Quality control device for solid, pharmaceutical products |
| 11/16/2005 | EP1594575A2 Modulation of atp production or content in the hypothalamus |